Tag: Cross-Canada Anaphylaxis Registry (C-CARE)

Allerject

Kaleo Announces Public and Private Insurance Plans to Cover Allerject, the...

Ontario and Quebec public drug plans are first to list ALLERJECT with other provinces expected to follow soon.
Questions

Suboptimal, inconsistent treatment for anaphylaxis due to unknown cause

New study sheds light on anaphylaxis due to an unknown trigger.
ER

Study: Fewer Than Half Use Their Epinephrine Auto-Injector Before Arriving at...

“It’s a disappointing reality that epinephrine is seriously underused.”
Adult and Child

Study: Food-Induced Anaphylaxis Common Among Children Under Adult Supervision

In majority of supervised reactions, adults other than the child’s parents were present.